Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2011 | 2.18 Million USD | -12.86% |
| 2010 | 2.51 Million USD | -19.31% |
| 2009 | 3.11 Million USD | -19.23% |
| 2008 | 3.85 Million USD | 26.82% |
| 2007 | 3.03 Million USD | 14.46% |
| 2006 | 2.65 Million USD | 29.39% |
| 2005 | 2.05 Million USD | 3263.93% |
| 2004 | 61 Thousand USD | -47.86% |
| 2003 | 117 Thousand USD | -5.65% |
| 2002 | 124 Thousand USD | -32.24% |
| 2001 | 183 Thousand USD | 471.88% |
| 2000 | 32 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 1.1 Million USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2011 FY | 2.18 Million USD | -12.86% |
| 2010 FY | 2.51 Million USD | -19.31% |
| 2009 FY | 3.11 Million USD | -19.23% |
| 2009 Q1 | 1.94 Million USD | -49.61% |
| 2008 Q2 | 3.4 Million USD | 8.38% |
| 2008 Q3 | 3.77 Million USD | 11.09% |
| 2008 Q4 | 3.85 Million USD | 2.04% |
| 2008 Q1 | 3.13 Million USD | 3.22% |
| 2008 FY | 3.85 Million USD | 26.82% |
| 2007 Q3 | 3.45 Million USD | -3.73% |
| 2007 Q1 | 2.65 Million USD | -0.08% |
| 2007 Q2 | 3.58 Million USD | 35.28% |
| 2007 Q4 | 3.03 Million USD | -12.04% |
| 2007 FY | 3.03 Million USD | 14.46% |
| 2006 FY | 2.65 Million USD | 29.39% |
| 2006 Q1 | 2.34 Million USD | 14.42% |
| 2006 Q2 | 2.67 Million USD | 13.76% |
| 2006 Q4 | 2.65 Million USD | -0.19% |
| 2006 Q3 | 2.66 Million USD | -0.41% |
| 2005 Q3 | 2.16 Million USD | -14.57% |
| 2005 FY | 2.05 Million USD | 3263.93% |
| 2005 Q1 | 47 Thousand USD | -22.95% |
| 2005 Q2 | 2.53 Million USD | 5289.36% |
| 2005 Q4 | 2.05 Million USD | -5.18% |
| 2004 Q2 | 90 Thousand USD | -13.46% |
| 2004 FY | 61 Thousand USD | -47.86% |
| 2004 Q4 | 61 Thousand USD | -18.67% |
| 2004 Q1 | 104 Thousand USD | -11.11% |
| 2004 Q3 | 75 Thousand USD | -16.67% |
| 2003 Q4 | 117 Thousand USD | -39.38% |
| 2003 FY | 117 Thousand USD | -5.65% |
| 2003 Q3 | 193 Thousand USD | 96.94% |
| 2003 Q1 | 109 Thousand USD | -12.1% |
| 2003 Q2 | 98 Thousand USD | -10.09% |
| 2002 FY | 124 Thousand USD | -32.24% |
| 2002 Q4 | 124 Thousand USD | -10.14% |
| 2002 Q3 | 138 Thousand USD | -1.43% |
| 2002 Q2 | 140 Thousand USD | -16.67% |
| 2002 Q1 | 168 Thousand USD | -8.2% |
| 2001 Q1 | 110 Thousand USD | 243.75% |
| 2001 FY | 183 Thousand USD | 471.88% |
| 2001 Q4 | 183 Thousand USD | -6.63% |
| 2001 Q3 | 196 Thousand USD | 2.62% |
| 2001 Q2 | 191 Thousand USD | 73.64% |
| 2000 Q2 | 113 Thousand USD | 156.82% |
| 2000 Q3 | 107 Thousand USD | -5.31% |
| 2000 Q4 | 32 Thousand USD | -70.09% |
| 2000 Q1 | 44 Thousand USD | 0.0% |
| 2000 FY | 32 Thousand USD | 0.0% |
| 1999 Q3 | - USD | -100.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q1 | 200 Thousand USD | 0.0% |
| 1999 Q2 | 100 Thousand USD | -50.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q1 | 100 Thousand USD | -90.91% |
| 1998 FY | - USD | -100.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | -100.0% |
| 1997 Q4 | 1.1 Million USD | 0.0% |
| 1997 Q2 | 1 Million USD | 0.0% |
| 1997 FY | 1.1 Million USD | 0.0% |
| 1997 Q3 | - USD | -100.0% |
| 1997 Q1 | - USD | 0.0% |
| 1996 Q3 | - USD | -100.0% |
| 1996 Q2 | 600 Thousand USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -337.8% |
| Ansell Limited | 855.59 Million USD | 99.744% |
| Ansell Limited | 857.2 Million USD | 99.745% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | 90.233% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -10356.174% |
| Psykey, Inc. | 1.01 Million USD | -116.604% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.833% |
| ConvaTec Group Plc | 1.31 Billion USD | 99.833% |
| Encision Inc. | 1.33 Million USD | -64.191% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 5.185% |
| Innovative MedTech Inc. | 1.87 Million USD | -16.546% |
| LifePoint, Inc. | 446.74 Thousand USD | -389.994% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | 59.419% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -802.145% |
| SmileDirectClub, Inc. | 871.79 Million USD | 99.749% |
| Sector 10, Inc. | 164 Thousand USD | -1234.756% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | 99.675% |
| SheerVision, Inc. | 75 Thousand USD | -2818.667% |
| United Health Products, Inc. | 755.98 Thousand USD | -189.554% |
| Vasamed, Inc. | 23.45 Thousand USD | -9234.755% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | 20.9% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -176.914% |